PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy targets tough cancers in early trial
Disease control OngoingThis study tests an experimental immunotherapy called ELI-002 7P in people with pancreatic or other solid tumors that have certain KRAS or NRAS gene mutations. The treatment aims to help the immune system fight cancer cells. The trial involves about 158 participants and is in ear…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Elicio Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 01:51 UTC
-
New drug trial targets Hard-to-Treat cancers
Disease control OngoingThis early-stage study tests a new drug, PF-08046052/SGN-EGFRd2, in people with advanced solid tumors that cannot be removed or have spread. The main goal is to check safety and side effects. About 68 participants with colorectal, lung, head/neck, or pancreatic cancer will take p…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Can a Pre-Surgery boost help cancer patients? new study tests nutrition, exercise, and mental support
Disease control OngoingThis study is testing whether an 8-week program of nutrition, exercise, and mental support before surgery can help people with pancreatic or esophageal cancer. The program includes personalized physical activity, diet check-ins, and psychological care if needed. The goal is to se…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New imaging tracer may reveal Chemo's reach in pancreatic cancer
Knowledge-focused OngoingThis early-phase study tests whether a special PET scan using an experimental tracer called 18F-FAC can show how much of the standard chemotherapy drug gemcitabine is taken up by pancreatic tumors. About 30 adults with pancreatic cancer will receive the tracer before starting tre…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:51 UTC